Product details

The primary subject matter of this case is the legal authority of the Food and Drug Administration to regulate sales and distribution of unapproved drugs over the Internet. The case illustrates the balance that must be struck among government regulations designed to insure the safety and efficacy of drugs, the rights of individuals to access and utilize unconventional treatments for life-threatening illnesses, and the freedom of entrepreneurs to engage in e-business without unnecessary government intervention and regulation. Secondary issues examined in the case are the ethical implications of marketing dubious cancer treatments over the Internet and government regulations restricting business operations in a free enterprise system. This case has a difficulty level of two or three, and is best utilized in a sophomore or junior level Business Law/Legal Environment or Business Ethics course. The case can be taught in a one hour session and requires two hours of preparation.